---
title: "Shibeikang announced the completion of Series B financing, with listed company CHENGDA PHARMA as the exclusive strategic investor"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/254716773.md"
description: "Recently, Chengdu Shibeikang Biopharmaceutical Technology Co., Ltd. announced the completion of its Series B financing. This round of financing was exclusively strategically invested by the listed company CHENGDA PHARMA. The funds raised will mainly be used to accelerate the construction of the R&D pipeline, expand the R&D laboratory, and promote the international application process of core products. According to Shibeikang, in its early entrepreneurial stage, it also received investments from industrial investors such as Fosun Pharma and Chuan Chuang Investment, as well as local investment institutions"
datetime: "2025-08-27T02:01:39.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/254716773.md)
  - [en](https://longbridge.com/en/news/254716773.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/254716773.md)
---

# Shibeikang announced the completion of Series B financing, with listed company CHENGDA PHARMA as the exclusive strategic investor

Recently, Chengdu Shibeikang Biopharmaceutical Technology Co., Ltd. announced the completion of its Series B financing. This round of financing was exclusively strategically invested by the listed company CHENGDA PHARMA. The funds raised will mainly be used to accelerate the construction of the R&D pipeline, expand the R&D laboratory, and promote the international application process of core products. According to Shibeikang, it previously received investments from industrial investors such as Fosun Pharma and Chuan Chuang Investment, as well as local investment institutions during its early startup phase

### Related Stocks

- [301201.CN](https://longbridge.com/en/quote/301201.CN.md)

## Related News & Research

- [Ray Dalio Says US Is in Decline: 'Threats No Longer Work' in a World Where Order Breaks Down](https://longbridge.com/en/news/294556219.md)
- [Is Citadel's Surprise July Rate Hike Call Viable? Jim Bianco Says 38% Market Odds Mean It's 'Not That Far'](https://longbridge.com/en/news/294029822.md)
- [Orion Diversified Holding buys 0.61% working interest in North Dakota Wiley Glenburn Unit](https://longbridge.com/en/news/293955142.md)
- [Muyuan Foods says Stock Exchange disciplinary statement on Redco does not affect director Chow Ming Sang’s duties](https://longbridge.com/en/news/294188255.md)
- [Thyssenkrupp Nucera hands over skid-mounted chlor-alkali plant to Chlorum Solutions in Brazil](https://longbridge.com/en/news/294180764.md)